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The accumulation  of polymorphonuclear leukocytes  (PMN) x plays an  important 
role  in  the  development  and  manifestations  of the  acute  inflammatory  response. 
Although the primary role of the neutrophil is destruction of invading microorganisms, 
potentially  harmful  substances  may be  released  from  neutrophils  with  subsequent 
damage to surrounding tissue (1). 
PMN  are thought  to move from the  vascular system and  accumulate  at  sites of 
inflammation by the process of directed  migration, or chemotaxis (2).  A  number of 
agents of both host and microbial origin have been shown to be capable of mediating 
this process (2). The extremely potent PMN chemoattractants released from Escherichia 
coli  (3)  have  been  partially  characterized  and  were  found  to  consist,  mainly,  of 
hydrophobic peptides with blocked N-terminal amino groups (4).  Schiffmann et al. 
(5) proposed that the bacterial factors could consist of N-formylmethionine containing 
peptides derived from bacterial proteins, since prokaryotes initiate  protein synthesis 
with N-formylmethionine. In support of this hypothesis, synthetic N-formylmethionine 
containing peptides were shown to be potent leukocyte attractants  (5, 6). 
In contrast to prokaryotes, the synthesis of proteins encoded in eukaryotic nuclear 
DNA is initiated with a nonformylated methionine residue  (7).  However, mitochon- 
dria,  present  in  eukaryotic cells, are also capable of protein synthesis  (8-10).  Mito- 
chondrial  DNA directs the synthesis of a  set of hydrophobic proteins,  found  in  the 
mitochondrial  respiratory  complexes  (8-10).  The  mitochondrial  protein  synthetic 
apparatus uses N-formylmethionine to initiate protein synthesis (8-10),  in a  manner 
similar  to  prokaryotes.  Importantly,  N-formylmethionine  has  been  shown  to  be 
retained  at  the  amino  terminus  of  several  purified  mitochondrially  synthesized 
proteins (11-13). 
It therefore seemed possible that N-formylmethionyl mitochondrial proteins could 
be chemotactic for PMN,  in a  manner similar to bacterial and synthetic N-formyl- 
methionine  peptides.  In  this  event,  mitochondrial  N-formylmethionine  containing 
peptides  released  from degenerating  mitochondria  at  sites  of tissue  damage  might 
play a  role in the accumulation of inflammatory cells observed at these sites. 
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We tested this possibility in  an  in  vitro system. The  present  report demonstrates 
that  disrupted  human  mitochondria  stimulate  PMN  chemotaxis  in  vitro.  Indirect 
evidence is presented to show that this chemotactic activity is mediated by mitochon- 
drially derived N-formylmethionyl proteins.  In  addition, purified mitochondrial N- 
formylmethionyl proteins were  found  to be chemotactic  for  PMN  in vitro, whereas 
nonformylated  mitochondrial  proteins,  tested  under  the same conditions, were  not 
chemotactic. 
Materials and  Methods 
Preparation of Leukocytes.  PMN  were  prepared  from  the  heparinized peripheral blood of 
healthy volunteers by Ficoll-Hypaque and dextran sedimentation (Ficoll-Paque and Dextran 
T-500; Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N.J.) (14). Remaining 
erythrocytes were removed by hypotonic lysis. Typical PMN  preparations contained >95% 
PMN, of which >95% excluded trypan blue. 
Assay of Chemotactic Activity.  Chemotaxis was  measured  by a  modification of the leading 
front assay described by Zigmond and Hirsch (15).  PMN were suspended at a density of 5 × 
106 cells/ml in medium  199  (MED  199) (GIBCO Laboratories, Grand Island Biological Co., 
Grand  Island,  N.  Y.)  containing  20  mM  HEPES,  2%  bovine  serum  albumin  (defatted), 
penicillin, and streptomycin, pH  7.4  (MED  199S).  The leukocytes were placed in the upper 
compartment of a chemotaxis chamber. A  5.0-#m micropore filter (Sartorius Membranfilter, 
Gottingen, West Germany) separated the upper and lower compartments. In all experiments, 
100#l of the chemotactic stimulus (diluted in MED 199S) was added to the lower compartment. 
Leukocytes were allowed to migrate for 45 min at 37°C, after which the filters were removed 
and stained with hematoxylin. PMN migration was determined as the mean distance that the 
leading two cells had migrated into the filter (15). In all experiments, five fields were averaged 
for each of triplicate filters. Stock preparations of disrupted mitochondria or purified mito- 
chondrial proteins (suspended in MED  199S containing 0. I% [vol/vol] Tween-80), as well as 
all other chemotactic factors, were diluted in MED 199S before testing chemotactic activity. In 
all cases, the final concentration of Tween-80 was not >0.006% (vol/vol). This concentration of 
detergent did not affect PMN migration under the present conditions. Controls, in which buffer 
alone (MED  199S, containing 0.006%  [vol/vol] Tween-80) was present in the lower compart- 
ment of the chemotaxis chamber, were always run (buffer control). Chemoattractants used as 
positive controls included human serum activated with zymosan (16) (Sigma Chemical Co., St. 
Louis,  Mo.)  and  the  synthetic  peptide  N-formylmethionyl-leucyl-phenylalanine (FMLP); 
(Sigma Chemical Co.)  (6). N-tert-butyloxycarbonyl-phenylalanine-leucine-phenylalanine-leu- 
cine-phenylalanine (BOC-Phe-Leu-Phe-Leu-Phe) was obtained from Peninsula Labs, Inc. (San 
Carlos, Calif.). When used, BOC-Phe-Leu-Phe-Leu-Phe (10 -6 M) was present in both the upper 
and  lower compartments of the chemotactic chamber  (17).  This agent  alone did not  affect 
PMN migration, under the present conditions. 
Isolation of Subcellular Organdies.  Mitochondria were prepared from cultured human cells by 
a  modification of the  digitonin washing  technique  described by Greenawalt  (18).  Aseptic 
conditions were maintained throughout  the isolation procedure. All steps were performed in 
9  the cold, unless otherwise noted. Washed cells (5  ×  10 )  were diluted in 3  vol of 100  mM 
sucrose (containing 20 mM HEPES, penicillin, and streptomycin, pH 7.4) and homogenized in 
a tight-fitting Teflon-on-glass Dounce homogenizer (Arthur H. Thomas Co., Philadelphia, Pa.). 
Immediately thereafter, mannitol was added (final concentration ofmannitol, 220 mM; sucrose, 
70 raM; HEPES,  15 mM, pH 7.4 [HMS]) and unbroken cells were pelleted by centrifugation 
at 1,000 g for 10 min. Homogenization was repeated until >70% of the nuclei were released, as 
determined  by phase-contrast  microscopy. Mitochondria were  pelleted from  the  combined 
supernatants by centrifugation at 5,100 g for  I0 rain. The resulting mitochondrial pellet was 
washed three times with HMS (5,100 g for 10 min) and suspended at a protein concentration 
of 100 mg/ml in the same buffer. 1 vol of the foregoing mitochondrial suspension was added to 
an equal volume of 1.2% (wt/vol) digitonin (Calbiochem-Behring Corp., American Hoechst 
Corp., San  Diego Calif.)  dissolved in  HMS  and  stirred for  15  min  on  ice, after which  the 
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hand,  and  centrifuged at  10,000 g  for  10  min.  The  resulting mitochondrial pellet was then 
washed  three  times with  HMS  (10,000  g  for  10  min),  suspended  in  MED  199S,  and  used 
immediately thereafter in  experiments in which  nondisrupted mitochondria were used.  For 
experiments in which disrupted mitochondria were used, the washed mitochondrial pellet was 
suspended at a protein concentration of 200 mg/ml in MED  199S  (containing 0.1%  (vol/vol) 
Tween-80)  and  sonicated  (Branson  Sonifier,  Branson  Sonic  Power  Co.,  Danbury,  Conn., 
maximum power setting) for seven cycles of 2 min, in the cold. Disrupted mitochondria thereby 
obtained were stored at  -80°C  before use. Lysosomes were isolated from HeLa cells by the 
technique described by Van Dijk et al. (19). Isolated lysosomes were suspended in MED  199S 
and sonicated (Branson Sonifier, maximum power setting) for three cycles of 2 min, in the cold, 
before use. A biochemical assessment of the purity of the isolated subcellular, organelles was 
obtained by the method  described by Leighton et  al.  (20),  assuming 22%  microsomal, 20% 
mitochondrial, and 1.0% lysosomal protein in the initial homogenate (21). Cytochrome oxidase 
(22),  glucose-6-phosphatase  (23),  and  acid  phosphatase  (24)  were  used  as  mitochondrial, 
microsomal, and lysosomal markers, respectively (21). Typical digitonin-washed mitochondrial 
preparations contained >90%  mitochondrial protein and not >5%  microsomal and 2% lyso- 
somal  contamination.  Typical  lysosomal  preparations  contained  not  >10%  mitochondrial 
contamination. 
Cell Culture.  HeLa cells (Flow Laboratories, Inc., Rockville, Md.) were suspension cultured 
in Eagle's minimum essential medium with Spinner Salts (GIBCO Laboratories) containing 
penicillin, streptomycin, and 5% calf serum. WI-38 (Flow Laboratories) and human  foreskin 
fibroblasts (a gift of Dr. L. Taichmann, State University of New York at Stony Brook) were 
cultured  in  Eagle's minimum  essential  medium  with  Earle's  Salts  (GIBCO  Laboratories) 
containing penicillin, streptomycin, and  10%  fetal calf serum, in roller bottles. All sera were 
heat inactivated at 56°C  for 30 rain, before use. In all cases, serum-containing medium was 
removed, and cells were washed with serum-free medium and maintained in serum-free culture 
for at least 8 h before harvesting. HeLa cells were harvested by centrifugation (1,000 g for 15 
rain);  WI-38 and  foreskin fibroblasts were  harvested by scraping with a  rubber policeman. 
After harvesting, all cell types were washed four times with at least 50 vol of phosphate-buffered 
saline  (containing penicillin and  streptomycin,  pH  7.4)  before  being  used  for  isolation of 
mitochondria or lysosomes. All cell cultures were checked (Hoecht's staining) and found to be 
free of mycoplasma contamination. 
Special Reagents and Assays.  Purified bovine heart mitochondrial cytochrome oxidase (CYOX) 
(22),  ATPase  (25),  ubiquinone-cytochrome c  reduetase  (complex  III)  (26),  and  succinate- 
coenzyme Q reductase (complex II)  (27) were gifts of Dr. R. Capaldi, University of Oregon. 
Stock preparations of all mitochondrial proteins were extensively dialyzed against MED  199S 
(containing 0.1%  [vol/vol] Tween-80)  before use.  In some experiments, cytochrome oxidase 
enzymatic activity was inhibited by treatment with NaN3 before dialysis. The immunoglobulin 
fraction of specific rabbit antibodies directed against bovine mitochondrial CYOX and ATPase 
were  prepared,  assayed, and  tested  for  specificity as  previously described  (28).  Antibodies 
directed against bovine mitochondrial CYOX and ATPase cross react immunologically with 
the  respective human  enzymes  (28).  Rabbit antibodies directed against the  third  and  fifth 
components of human complement, as well as control rabbit immunoglobulin, were obtained 
from Accurate Chemical & Scientific Corp. (Westbury, N. Y.).  The immunoglobulin fraction 
of all of the foregoing antisera were used in chemotaxis experiments, following dialysis against 
MED  199 and heating at 56°C  for 30  min. Protein concentration was determined using the 
Bio-Rad protein assay (Bio-Rad Laboratories, Richmond, Calif.) with ovalbumin as standard. 
Results 
Chemotactic Activity  of Disrupted Mitochondria.  To study the effect of mitochondrial 
proteins  on  neutrophil  migration  in  vitro,  mitochondria  were  isolated  from  three 
cultured human cell types. Mitochondria isolated from HeLa cells, WI-38, and human 
foreskin  fibroblasts  were  disrupted  and  tested  for  PMN-ehemotactic  activity,  as 
described in  Materials and  Methods.  As shown  in Table I, disrupted mitochondria 
from all of the cell types tested stimulated PMN  migration in vitro. The most active HARVEY  CARP  267 
TABLE  1 
Chemotactic Activity of Disrupted Mitochondria 
Chemotactic  factor  Migration into filter of 
leading cell front 
Source  Protein*  PMN chemotaxis:~ 
ktg  #m 
Buffer control  --  39 ±  1.7 
HeLa-Mito§  100  94 -  7.3 II 
HeLa-Mito§  10  64 + 3.0 II 
HeLa-Mito§  1.0  42 ± 2.0 
WI-38-Mito§  100  130 ±  7,2 I[ 
WI-38-Mito§  10  70 ± 5.1 1[ 
WI-38-Mito§  1.0  40 :t: 3,0 
Foreskin-Mito§  I00  123 ± 8,9 11 
Foreskin-Mito§  10  69 ± 5.3 II 
Foreskin-Mito§  1.0  58 ± 2.6 I[ 
Foreskin-Mito§  0.1  40 ± 2.0 
* Amount of mitochondrial protein added to the stimulus compartment of the 
chemotaxis chamber. 
:~ Ghemotactic  activity is expressed as  the  mean  ±  1 SE of at  least  three 
experiments, each performed in triplicate. 
§ Mitochondria isolated from HeLa cells (HeLa-Mito), human foreskin fibro- 
blasts (foreskin-Mito), and WI-38 fibroblasts (WI-38-Mito) were disrupted 
before chemotactic assay, as described in Materials and Methods. 
]1P < 0.05 compared with buffer control (Student's t test). 
preparation  (foreskin fibroblast) stimulated migration when  1.0 #g of mitochondrial 
protein  was  present  in  the  stimulus  compartment  of the  chemotaxis  chamber  (see 
Table I). 
In  the  foregoing  experiments,  disruption  of  the  isolated  mitochondria,  before 
chemotactic  testing,  was  necessary  to  demonstrate  significant  chemotactic  activity. 
However, after incubation of nondisrupted HeLa cell mitochondria with a  lysosomal 
lysate  (from  the  same  cells)  for  1  h  at  37°C  in  MED  199S  (pH  7,0),  significant 
chemotactic  activity  was  detected  (microns  migrated  leading  front  PMN:  buffer 
control  =  42  +  2.1  /zm;  HeLa-mitochondria,  nondisrupted  [100  /zg]  47  _  1.9 #m; 
HeLa-mitochondria, nondisrupted  [100 #g]  +  HeLa lysosomes [20 #g]  71  _  2.7/~m; 
mean of three experiments +  1 SE). Lysosomes alone were not:chemotactic and boiled 
lysosomes did not activate nondisrupted mitochondria (data not shown). 
Characterization of Mitochondrial Chemotactic Activity.  To  date,  mitochondrially syn- 
thesized  N-formylmethionyl  proteins  have  been  identified  as  components  of mito- 
chondrial  CYOX,  ATPase,  and  complex  III  (8-13).  Therefore,  specific antibodies 
directed against  mitochondrial  CYOX  and  ATPase were  tested  for  their ability to 
block the chemotactic activity of disrupted mitochondria in vitro. To assure maximum 
inhibition of chemotaxis, disrupted mitochondria were  preincubated with  a  combi- 
nation  of specific anti-CYOX  and  ATPase  antibodies.  After  15  min  at  37°C,  the 
remaining chemotactic activity was measured as before. As shown  in Table II, such 
treatment significantly decreased the chemotactic activity of disrupted mitochondria. 
(Pretreatment with anti-CYOX or anti-ATPase, separately, also resulted in a decrease 
in chemotactic activity [data not  shown]).  Control  rabbit immunoglobulin  (Ig)  was 
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TABLE II 
Characterization of Mitochondrial Chemotactic Activity 
Chemotactic factor* 
Migration into filter of leading front PMN~: 
Treatment of chemotactic factor§ 
Anti-CYOX 
None  + anti-  Anti-C:~ 
ATPase 
Anti-C.~  Ig 
#m  gm  gm  gm  /Lm 
HeLa-Mito II  87 ± 5.2  60 + 3.1¶  89 --- 6.0  92 + 4.9  89 ± 2.2 
WI-38-Mito 11  118±5.0  78±4.7¶  122+3.9  115 ± 2.9  115±4.0 
Foreskin-Mito II  101 ± 3.9  73 ± 4.8¶  96 + 3.1  105 ±. 4.0  106 ± 3.5 
Activated serum  130 ± 4.0  NT**  NT  55 ± 2.4¶  NT 
FMLP  119 ± 3.1  124 ± 2.2  NT  NT  NT 
Buffer control  37 ± 2.0  43 +- 2.9  39 + 3.0  40 :lz 1.7  36 + 2.2 
* Concentrations: activated (zymosan) human serum, 10% (vol/vol); FMLP, 10  -s M; HeLa, WI-38, and 
foreskin fibroblast mitoehondria, 100 gg (protein). In all cases chemotactic factors were present only in 
the stimulus compartment of the chemotaxis chamber. 
:~ Chemotactic activity is expressed as the mean ±  1 SE of at least three experiments, each performed in 
triplicate. 
§ 5/~1 of anti-C5 (25 mg/ml), anti-C3 (25 mg/ml), anti-CYOX + anti-ATPase (25 mg/ml), or rabbit Ig 
(25 mg/ml) was incubated with 100 gl of chemotactic factor for 15 min at 37°C before chemotactic 
assay. 
[I Mitochondria isolated from HeLa cells (HeLa-Mito), foreskin fibroblasts (foreskin-Mito),  and WI-38 
fibroblasts (WI-38-Mito) were disrupted  before chemotactic assay, as  described in  Materials  and 
Methods. 
¶ P < 0.05, compared with untreated control sample (Student's t test). 
** Not tested. 
not chemotactic alone (Table II) nor did they affect the PMN chemotactic response 
to FMLP (Table II). 
The  inhibition of mitochondrially derived PMN-chemotactic activity by specific 
antibodies directed  against two  mitochondrially synthesized proteins, suggests  that 
these proteins may have been responsible for at least part of this activity. In addition, 
antigenic fragments of partially degraded or incompletely synthesized mitochondrial 
proteins may have also played a  role. These conclusions are also consistent with the 
inability of antibodies directed against the third  (Ca)  and fifth  (C5) components of 
complement to  inhibit mitochondrially derived chemotactic activity (see  Table II). 
This  suggests  that  complement components were  not  involved under  the  present 
conditions. 
Chemotactic Activity of Purified Mitochondrial Proteins.  We further tested the hypothesis 
that  mitochondrially synthesized, N-formylmethionyl proteins  are  chemotactic  for 
PMN in experiments using purified bovine heart mitochondrial proteins in place of 
disrupted mitochondria. Both formylated and nonformylated mitochondrial proteins 
were  tested.  Mitochondrial CYOX  contains seven protein subunits (22).  Subunits 
I-III are synthesized by the mitochondria (8-10,  12,  13,  29)  and subunits I  and II 
have been shown to  contain N-formylmethionine residues  (12,  13).  The  remaining 
subunits of CYOX  (subunits IV-VII) are synthesized in the cytoplasm and do  not 
contain  N-formylmethionine (8-10,  12,  13,  29).  As  shown  in  Fig.  1,  cytochrome 
oxidase (holoenzyme) and subunits I-II (mitochondrially synthesized) all stimulated 
PMN migration in vitro (see  Fig.  1 A), whereas cytochrome oxidase subunits IV-VI 
(cytoplasmically synthesized) did not (see Fig.  1 B). Inhibition of cytochrome oxidase § 
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FIo.  1.  Chemotactic activity of purified mitochondrial proteins. Chemotactic activity is plotted as 
the migration (in microns) into the filter of the leading front PMN. Each point represents the mean 
±  1 SE  of at  least  three experiments, each  performed  in  triplicate.  The abscissa represents the 
concentration  of chemotactic  factor  present  in  the  stimulus compartment  of  the  chemotactic 
chamber. Panel A shows the chemotactic activity of N-formylmethionine containing mitochondrial 
proteins. Panel B shows the activity of mitochondrial proteins not containing N-formylrnethionine. 
CYOXI, CYOXn, CYOXw, CYOXv, CYOXvI: CYOX subunits I, II, IV, V, and VI, respectively. 
enzymatic activity with NaN3 did not affect chemotactic activity (data not shown). 
Mitochondrial  ATPase  and  complex  III,  both  of which  contain  mitochondrially 
synthesized subunits (8-11), also stimulated PMN migration (Fig.  1 A). Furthermore, 
mitochondrial complex II, which does not contain mitochondrially synthesized sub- 
units (8-10),  did not stimulate PMN migration (see Fig.  1B). The results in Fig.  1 
demonstrate that mitochondrially synthesized N-formylmethionyl proteins are capa- 
ble of stimulating PMN  chemotaxis in  vitro, whereas cytoplasmically synthesized, 
nonformylated mitochondrial proteins,  tested  under  the  same  conditions,  did  not 
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Inhibition of Mitochondrial Chemotactic Activity  by BOC-Phe-Leu-Phe-Leu-Phe.  We  fur- 
ther tested  the notion that  the PMN  chemotactic  activity of mitochondrially  synthe- 
sized proteins  is mediated  through  the presence of an N-formylmethionine residue by 
using the formyl peptide antagonist  BOC-Phe-Leu-Phe-Leu-Phe  (17,  30).  BOC-Phe- 
Leu-Phe-Leu-Phe  is  thought  to  inhibit  the  PMN  response  to  N-formylmethionine 
containing peptides by competitively inhibiting the binding of these factors to specific 
cell  surface  receptors  (2,  17,  30).  As  shown  in  Table  III,  when  BOC-Phe-Leu-Phe- 
Leu-Phe  was  present  in  both  compartments  of the  chemotaxis  chamber,  the  PMN 
chemotactic  response  to  purified  mitochondrial  proteins  or  disrupted  mitochondria 
was significantly reduced.  Under the conditions in Table III, BOC-Phe-Leu-Phe-Leu- 
Phe alone did not affect PMN  migration to zymosan-activated serum  (see Table  III), 
whereas  the  PMN  chemotactic  response  to  FMLP  was  significantly  decreased  (see 
Table III). The findings using BOC-Phe-Leu-Phe-Leu-Phe  suggest that mitochondrial 
PMN  chemoattractants  interact with neutrophil N-formylmethionyl peptide receptors 
(2,  17,  30)  and  imply  that  the  chemotactic  activity of disrupted  mitochondria  and 
purified  mitochondrial  proteins  is  mediated,  at  least  in  part,  through  N-formylme- 
thionine residues present  in these proteins. 
Disrupted Mitochondria and Purified Mitochondrial Proteins Stimulate PMN Directed Migra- 
TABLE  III 
Effect of BOC-Phe-Leu-Phe-Leu-Phe  on Mitochondrially Derived 
Chemotactic Activity 
Chemotactic factor* 
PMN chemotaxis~ 
Without BOC-Phe-  With BOC-Phe-Leu- 
Leu-Phe-Leu-Phe  Phe-Leu-Phe§ 
Buffer control  44 ±  3.5 
CYOX  99 -+ 5.2 
CYOXt  109 -+ 5.7 
CYOXu  89 +  5.0 
ATPase  102 ± 4.3 
HeLa-Mito**  85 ±  5.0 
WI-38-Mito**  94 _+ 5.4 
Foreskin-Mito**  120 _+ 3.8 
FMLP  115 _+ 3.8 
Activated serum  125 ±  3.4 
~m 
45 -+ 2.2 
56 ±  3.2  ¶ 
61  +4.5  ¶ 
59_+4.0  ¶ 
70_+3.7  ¶ 
64 +  3.8  ¶ 
70-+5.0  ¶ 
79± 6.1  ¶ 
67+_3.1  ¶ 
129 +  3.7 
* Concentrations:  CYOX,  10 6 M;  CYOX  subunit  I  (CYOXI),  10-"  M; 
CYOX subunit  lI (CYOXn),  10 -~ M; activated (zymosan)  human serum, 
10% (vol/vol); FMLP,  10  -s M; HeLa WI-38, and foreskin fibroblast  mito- 
chondria,  100 ~g (protein).  In all cases, chemotactic factors  were present 
only in the stimulus compartment of the chemotaxis chamber. 
§ BOC-Phe-Leu-Phe-Leu-Phe (10  -# M) was present  in both upper and lower 
compartments of the chemotaxis chamber. 
:~ Chemotactic activity is expressed  as  the  mean  +  1 SE of at  least  three 
experiments, each performed in triplicate. 
[] P <  0.05, compared with buffer control (Student's t test). 
¶ P  <  0.05,  compared  with  sample  without  BOC-Phe-Leu-Phe-Leu-Phe 
(Student's t test). 
** Mitochondria  isolated  from  HeLa cells  (HeLa-Mito), foreskin  fibroblasts 
(foreskin-Mito),  and WI-38 fibroblasts  (WI-38-Mito)  were disrupted before 
chemotaxis assay, as described in Materials and Methods. HARVEY  CARP  271 
TABLE IV 
Stimulation of Directed Cell Migration by Disrupted Mitochondria and 
Purified Mitochondrial Protein 
Contents of chamber compartment* 
Upper  Lower 
Migration into filter of 
leading front PMN:~ 
Buffer +  PMN  Buffer  37 ±  1.2 
HeLa-Mito§ +  PMN  HeLa-Mito§  65 +_ 2.2 II 
Buffer +  PMN  HeLa-Mito§  85 :t: 3.01[  ¶ 
CYOX +  PMN  CYOX  59 ±  2.9 II 
Buffer +  PMN  CYOX  87 ±  3.6 II  ** 
* Concentrations: CYOX, 10  -5 M; HeLa-Mito, I00/zg (protein). 
:~ Chemotaetic activity  is  expressed as the mean  ±  1 SE of at  least  three 
experiments, each performed in triplicate. 
§ Mitochondria disrupted before chemotactic assay, as described in Materials 
and Methods. 
II P <  0.05, compared with migration with buffer alone in both compartments 
(Student's t test). 
¶ P <  0.05, compared with migration with HeLa-Mito in both compartments 
(Student's t test). 
** P  <  0.05,  compared with migration with CYOX  in  both compartments 
(Student's t test). 
tion  (Chemotaxis).  To determine whether  disrupted  mitochondria or purified  mito- 
chondrial proteins stimulated directed PMN migration (chemotaxis) or only increased 
random PMN migration, experiments were performed in which active material was 
placed in various compartments of the chemotactic chamber (15).  As shown in Table 
IV, there was significantly less PMN migration when disrupted HeLa cell mitochon- 
dria or CYOX  were  present  at  equal  concentrations  in  both  compartments of the 
chemotactic  chamber,  as  opposed  to  when  PMN  were  exposed  to  a  gradient  of 
stimulus  (i.e.,  mitochondria or CYOX were present only in the lower compartment). 
However, both of these combinations produced significantly more cell migration than 
exposure of PMN to buffer alone (Table IV). Similar results were obtained with WI- 
38 and foreskin mitochondria, as well as with  mitochondrial ATPase.  These results 
suggest that disrupted mitochondria and purified mitochondrial proteins are capable 
of stimulating directed  PMN migration  (chemotaxis),  as well as random  migration 
(15). 
Discussion 
Previous  studies  have  demonstrated  that  a  number  of agents  of both  host  and 
microbial origin posess potent PMN chemotactic activity (2).  These include comple- 
ment fragments (16, 31), oxidized lipids  (32), connective tissue breakdown products 
(33), as well as factors derived from macrophages (34)  and bacterial cells (3, 4). All of 
these agents are believed to play an important role in the accumulation of PMN at 
sites  of  inflammation  in  vivo.  In  addition  to  other  factors,  N-formylmethionine 
containing proteins released from degenerating mitochondria at sites of tissue injury 
may also play a  role in the accumulation of inflammatory cells at such sites. 
In this context it is important to note that mitochondrial degeneration is a sensitive 
indicator of cellular damage (35).  In fact, mitochondrial enzymes have been reported 272  MITOCHONDRIAL CHEMOATTRACTANTS 
to be present, in small amounts, in the circulation following injury to myocardial or 
hepatic tissue in man (36). Although the tissue concentration of  released mitochondrial 
proteins  in  vivo is  not  known,  based  on  the results  of the  present  study it  can  be 
estimated that the quantity of mitochondrially synthesized protein present in 250 mg 
of cardiac muscle (29) would give significant in vitro chemotactic activity. 
Degradative enzymes present in tissue lysosomes have been shown to be capable of 
disrupting mitochondrial structure and function in vitro (37, 38). Our results suggest 
that lysosomally mediated mitochondrial disruption also results in the release of PMN 
chemoattractants from mitochondria. Oxygen radicals and lysosomal granule enzymes 
derived from PMN  (1),  initially attracted to an inflammatory site by nonmitochon- 
drially derived chemotactic factors, may also aid in the disruption of mitochondria, 
with  resultant  release  of mitochondrial  PMN  chemoattractants.  Furthermore,  if 
released mitochondrial N-formylmethionine-containing proteins are capable of stim- 
ulating  PMN  degranulation  in  a  manner  similar  to  synthetic N-formylmethionyl 
peptides  (6),  they  could  serve  as  an  amplificaion  loop  for  further  generation  of 
chemotactic factor. Although native mitochondrial proteins were found to be chem- 
otactic, partially degraded fragments (as well as incompletely synthesized fragments) 
produced as a result of mitochondrial degradation, may also attract PMN. Additional 
studies are necessary to clarify the conditions leading to the release of mitochondrial 
N-formylmethionyl proteins and the effects of the released proteins on PMN, as well 
as other inflammatory cells. 
In the present study, purified bovine heart mitochondrial proteins were shown to 
be  chemotactic  for  neutrophils.  The  analagous  human  proteins  were  not  tested. 
However, when  examined,  bovine  and  human  mitochondrial  proteins  have  been 
found to be closely related in structure (22,  29, 39). In fact, there is a  72% sequence 
homology  between  bovine  CYOX  subunit  II  used  in  the  present  study  and  the 
analogous human protein (39).  It is also interesting to note that the amino terminal 
sequence  of bovine  CYOX  subunit  I  begins  with  the  amino  acid  sequence  N- 
formylmethionine-phenylalanine (13).  This is identical to the sequence of a  known 
synthetic PMN chemotactic peptide (6). Further studies using purified human mito- 
chondrial proteins are necessary to extend the present results. 
Disrupted  mitochondria  isolated  from  cultured  human  cells  were  found  to  be 
chemotactic for PMN. Although cultured cells are known to acquire characteristics in 
vitro not  displayed  by  these cells  in  vivo, two of the  cell  types  used  (WI-38  and 
foreskin  fibroblasts)  were  low  passage,  diploid  cells.  Furthermore,  a  preliminary 
experiment  suggested  that  mitochondria  isolated  from  fresh  dog  heart  were  also 
chemotactic for PMN in vitro (H. Carp, unpublished observation). However, addi- 
tional studies using mitochondria isolated from fresh human  tissue are necessary to 
confirm our results obtained using cultured cells. 
Complement components are extremely potent PMN chemotactic agents  (2,  31). 
Although a previous study (40) showed that human heart mitochondrial membranes 
interact with  the complement system in  vitro, chemotactic activity was  not  tested. 
However, under the conditions of the present study, complement components were 
not present in significant concentrations (i.e., serum-free chemotaxis medium and at 
least 8 h serum-free cell culture before mitochondrial isolation). In addition, anti-C3 
and anti-C5 antibodies did not inhibit mitochondrial chemotactic activity. Although 
complement components play an important role in the accumulation of PMN in vivo HARVEY  CARP  273 
(2,  31, 41), under the present in vitro conditions complement did not appear to be 
involved. 
Finally, in addition to mammalian cells, other eukaryotic cells, including fungi and 
protozoa (several of which are pathogenic for man  [42])  also contain mitochondria 
(8-10). N-formylmethionine containing proteins released from these organisms might 
also attract inflammatory cells. 
Many questions remain, and further studies are necessary to determine whether the 
release of mitochondrial N-formylmethionyl proteins plays a  role in  mediating the 
accumulation  of inflammatory  cells  observed  at  sites  of tissue  damage  in  vivo. 
However, we believe our in vitro results support this possibility and render it worthy 
of further study. 
Summary 
Mitochondria synthesize several hydrophobic proteins. Like bacteria, mitochondria 
initiate protein synthesis with an N-formylmethionine residue. Because N-formylme- 
thionyl peptides have been found to be chemotactic for polymorphonuclear leukocytes 
(PMN), mitochondria isolated from cultured human cells and purified bovine mito- 
chondrial  proteins  were  tested  for  PMN  chemotactic  activity  in  vitro.  Isolated 
mitochondria,  following disruption,  stimulated  PMN  migration  in  vitro.  Nondis- 
rupted mitochondria were not chemotactic. However, intact mitochondria that had 
been incubated with a  lysosomal lysate did stimulate  PMN  migration.  Antibodies 
directed against two mitochondrial enzymes, cytochrome oxidase and ATPase, (both 
of which contain  mitochondrially synthesized subunits)  but  not  anti-Ca or anti-C5 
decreased mitochondrially derived chemotactic activity. In addition, purified bovine 
mitochondrial  N-formylmethionyl  proteins  stimulated  PMN  migration  in  vitro, 
whereas nonformylated mitochondrial proteins did not. Furthermore, the chemotactic 
activity of purified mitochondrial proteins and disrupted mitochondria was decreased 
by  the  formyl  peptide  antagonist  butyloxycarbonyl-phenylalanine-leucine-phenyl- 
alanine-leucine-phenylalanine.  Finally,  disrupted  mitochondria  and  purified  mito- 
chondrial  proteins stimulated  PMN-directed  migration  (chemotaxis),  according to 
accepted criteria.  In  addition  to other chemotactic factors, release of N-formylme- 
thionyl proteins from mitochondria at sites of tissue damage, may play a rote in the 
accumulation of inflammatory cells at these sites. 
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